Study authors assessed the effectiveness of high-dose influenza vaccines in patients with HIV during the 2017-2018 influenza season.
Investigators conducted a randomized, open-label trial during the 2018-2019 influenza season to assess neutralization titers in pre- and post-immunization sera from 133 adults immunized with one of three types of influenza vaccines.
One-third of parents say they will forgo influenza vaccination for their children this year, despite public health recommendations.
Researchers evaluated prevalence of and sociodemographic disparities in influenza vaccination among individuals with ASCVD.
There was very low influenza activity from June to August 2020 in the Southern Hemisphere.
During the upcoming flu season, it is essential to ensure a high coverage rate of vaccination, particularly among populations who are vulnerable to COVID-19.
The efficacy and safety of pimodivir, an inhibitor of influenza virus polymerase basic protein 2, was being investigated in two phase 3 studies.
Acute heart failure and acute ischemic heart disease are most common cardiovascular events in adults hospitalized with influenza.